149 related articles for article (PubMed ID: 11127579)
21. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats.
Ueno H; Sakamoto T; Nakamura T; Qi Z; Astuchi N; Takeshita A; Shimizu K; Ohashi H
Hum Gene Ther; 2000 Jan; 11(1):33-42. PubMed ID: 10646637
[TBL] [Abstract][Full Text] [Related]
22. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo.
Mehrara BJ; Saadeh PB; Steinbrech DS; Dudziak M; Spector JA; Greenwald JA; Gittes GK; Longaker MT
J Bone Miner Res; 1999 Aug; 14(8):1290-301. PubMed ID: 10457261
[TBL] [Abstract][Full Text] [Related]
24. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
25. Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo.
Ikeda Y; Imai Y; Kumagai H; Nosaka T; Morikawa Y; Hisaoka T; Manabe I; Maemura K; Nakaoka T; Imamura T; Miyazono K; Komuro I; Nagai R; Kitamura T
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10732-7. PubMed ID: 15247411
[TBL] [Abstract][Full Text] [Related]
26. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
Ozawa S; Uchiyama K; Nakamori M; Ueda K; Iwahashi M; Ueno H; Muragaki Y; Ooshima A; Yamaue H
Surgery; 2006 Apr; 139(4):563-73. PubMed ID: 16627068
[TBL] [Abstract][Full Text] [Related]
27. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation.
Oshima T; Sonoda KH; Nakao S; Hijioka K; Taniguchi M; Ishibashi T
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):105-12. PubMed ID: 18172081
[TBL] [Abstract][Full Text] [Related]
28. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462
[TBL] [Abstract][Full Text] [Related]
29. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
Kingston PA; Sinha S; Appleby CE; David A; Verakis T; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2003 Dec; 108(22):2819-25. PubMed ID: 14638551
[TBL] [Abstract][Full Text] [Related]
31. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
32. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
33. Reduced programmed cell death in the retina and defects in lens and cornea of Tgfbeta2(-/-) Tgfbeta3(-/-) double-deficient mice.
Dünker N; Krieglstein K
Cell Tissue Res; 2003 Jul; 313(1):1-10. PubMed ID: 12838410
[TBL] [Abstract][Full Text] [Related]
34. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
35. [Effect of blocking transforming growth factor beta signalling on culture-activated rat hepatic stellate cells].
Zhou YJ; Yin DM; Chen HS; Zhu HX; Wang X
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):282-4. PubMed ID: 12773242
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta expression in rat eyes with mechanical debridement of corneal epithelium or epithelial flap.
Lee JJ; Kim MK; Shin KS; Shin MS; Wee WR; Lee JH
J Cataract Refract Surg; 2008 Apr; 34(4):662-9. PubMed ID: 18361991
[TBL] [Abstract][Full Text] [Related]
37. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.
Galeano M; Deodato B; Altavilla D; Squadrito G; Seminara P; Marini H; Stagno d'Alcontres F; Colonna M; Calò M; Lo Cascio P; Torre V; Giacca M; Venuti FS; Squadrito F
Crit Care Med; 2003 Apr; 31(4):1017-25. PubMed ID: 12682466
[TBL] [Abstract][Full Text] [Related]
38. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
[TBL] [Abstract][Full Text] [Related]
40. Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice.
Flügel-Koch C; Ohlmann A; Piatigorsky J; Tamm ER
Dev Dyn; 2002 Oct; 225(2):111-25. PubMed ID: 12242711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
